These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1391 related articles for article (PubMed ID: 32760014)

  • 1. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.
    Galluzzi L; Humeau J; Buqué A; Zitvogel L; Kroemer G
    Nat Rev Clin Oncol; 2020 Dec; 17(12):725-741. PubMed ID: 32760014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitors: a promising anticancer therapy.
    Singh S; Hassan D; Aldawsari HM; Molugulu N; Shukla R; Kesharwani P
    Drug Discov Today; 2020 Jan; 25(1):223-229. PubMed ID: 31738877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.
    Hayase E; Jenq RR
    Genome Med; 2021 Jun; 13(1):107. PubMed ID: 34162429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting tumor responders and predictive biomarkers of toxicities in cancer patients treated with immune checkpoint inhibitors.
    Yao L; Jia G; Lu L; Bao Y; Ma W
    Int Immunopharmacol; 2020 Aug; 85():106628. PubMed ID: 32474388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities?
    Przybylski DJ; Bergsbaken JJ; Piccolo JK
    J Oncol Pharm Pract; 2021 Jun; 27(4):930-938. PubMed ID: 33406979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer.
    Kobayashi Y; Lim SO; Yamaguchi H
    Semin Cancer Biol; 2020 Oct; 65():51-64. PubMed ID: 31874279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to select cancer patients for immunotherapy.
    Pfeiffer P; Qvortrup C; Hansen KH
    EBioMedicine; 2021 Jan; 63():103184. PubMed ID: 33418504
    [No Abstract]   [Full Text] [Related]  

  • 8. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations.
    Abid MB
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic Cells and Their Role in Immunotherapy.
    Gardner A; de Mingo Pulido Á; Ruffell B
    Front Immunol; 2020; 11():924. PubMed ID: 32508825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
    Ruiz de Porras V; Pardo JC; Notario L; Etxaniz O; Font A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities.
    Xu Y; Fu Y; Zhu B; Wang J; Zhang B
    Front Immunol; 2020; 11():2023. PubMed ID: 33123120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.
    Hu Y; Gong J; Zhang L; Li X; Li X; Zhao B; Hai X
    Int Immunopharmacol; 2020 Jul; 84():106601. PubMed ID: 32422528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibition for the treatment of cancers: An update and critical review of ongoing clinical trials.
    Akhbariyoon H; Azizpour Y; Esfahani MF; Firoozabad MSM; Rad MR; Esfahani KS; Khoshavi N; Karimi N; Shirinisaz A; Abedi F; Rad MR; Sharifi P
    Clin Immunol; 2021 Nov; 232():108873. PubMed ID: 34688855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitor associated neurotoxicity: Much more than meets the eye.
    Raibagkar P
    Immunol Lett; 2020 May; 221():72-74. PubMed ID: 32092358
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune Checkpoint Inhibitors-induced Myasthenia Gravis: From Diagnosis to Treatment].
    Yao S; Li X; Nong J; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):685-688. PubMed ID: 32752585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
    Franzin R; Netti GS; Spadaccino F; Porta C; Gesualdo L; Stallone G; Castellano G; Ranieri E
    Front Immunol; 2020; 11():574271. PubMed ID: 33162990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Etiology of Hypophysitis: Immune Checkpoint Inhibitors.
    Fernandes S; Varlamov EV; McCartney S; Fleseriu M
    Endocrinol Metab Clin North Am; 2020 Sep; 49(3):387-399. PubMed ID: 32741478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Immune Checkpoint Inhibitors in Colorectal Adenocarcinoma.
    Almquist DR; Ahn DH; Bekaii-Saab TS
    BioDrugs; 2020 Jun; 34(3):349-362. PubMed ID: 32246441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review).
    Yu S; Xiong G; Zhao S; Tang Y; Tang H; Wang K; Liu H; Lan K; Bi X; Duan S
    Int J Mol Med; 2021 Feb; 47(2):444-454. PubMed ID: 33416134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitors: The linchpins of modern immunotherapy.
    Wilky BA
    Immunol Rev; 2019 Jul; 290(1):6-23. PubMed ID: 31355494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.